Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version 44 adds Contacts/Locations, Study Design, and Study Status and updates the revision to v3.5.2; the previous revision v3.5.0 was removed on 2025-11-13.
    Difference
    0.4%
    Check dated 2026-04-16T10:28:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows the latest revision as v3.5.0, replacing the previous v3.4.3. This updates the revision indicator without altering study data.
    Difference
    0.1%
    Check dated 2026-03-25T19:36:54.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed in the record history.
    Difference
    0.1%
    Check dated 2026-03-11T14:11:52.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The history shows an added Revision: v3.4.2 and deletions of a funding notice and Revision: v3.4.1; these are administrative site maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:29:30.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:18:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and notes explaining the color-coded changes (green and red highlights). The revision metadata was updated to v3.4.0 and the No FEAR Act data item was removed.
    Difference
    0.6%
    Check dated 2026-01-28T04:25:34.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.